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Neural Targeting of Mycobacterium leprae
Mediated by the G Domain of the Laminin-a2
Chain
Anura Rambukkana,* James L. Salzer,² pathogen. Thus, a specific Schwann cell±M. leprae affin-
ity is likely to underlie the unique neural tropism of thePeter D. Yurchenco,³ and Elaine I. Tuomanen*
disease. Although in vitro nerve tissue cultures recapitu-*Laboratory of Molecular Infectious Diseases
late the neural tropism of M. leprae (Lumsden, 1959;The Rockefeller University
Mukherjee and Antia, 1986), virtually nothing is knownNew York, New York 10021
about the molecular basis of this neural affinity. In this²Departments of Cell Biology, Neurology
study, we establish the molecules that mediate this bac-and the Kaplan Cancer Center
terial±host cell interaction.New York University Medical Center
Pathogenic bacteria attach to their preferred host tar-New York, New York 10016
get by molecules on the bacterial surface, termed ad-³Department of Pathology
hesins, that recognize cognate host-cell receptors (Fal-Robert Wood Johnson Medical School
kow, 1991; Tuomanen et al., 1995). This attachment canPiscataway, New Jersey 08854
be achieved by direct binding or indirectly by adsorbing
a bridging ligand of host origin onto the bacterial sur-
face, which then enables the pathogen to ªtag alongº
a natural pathway determined by bridging ligand±hostSummary
receptor interactions (Hoepelmann and Tuomanen,
1992). In this regard, the integrin family of host-adhesionWe report that the molecular basis of the neural tro-
molecules that mediate cell±cell and cell±extracellularpism of Mycobacterium leprae is attributable to the
matrix contacts have gained much attention as cognatespecific binding of M. leprae to the laminin-a2 (LN-a2)
receptors for bacterial adhesion and entry (Isberg andchain on Schwann cell±axon units. Using recombinant
Leong, 1990; Relman et al., 1990).fragments of LN-a2 (rLN-a2), the M. leprae-binding
In the endoneurium of peripheral nerve, all Schwannsite was localized to the G domain. rLN-a2G mediated
cells are covered by basal lamina, a characteristic fea-M. leprae binding to cell lines and to sciatic nerves of
ture that distinguishes Schwann cells from fibroblastsdystrophic dy/dy mice lacking LN-a2, but expressing
and macrophages (Gamble and Eames, 1964). Since M.laminin receptors. Anti-b4 integrin antibody attenuated
leprae must interact with the basal lamina in order torLN-a2G-mediated M. leprae adherence, suggesting
reach the Schwann cell, tropism to this site and perhapsthat M. leprae interacts with cells by binding to b4
cellular entry might involve the components of Schwannintegrin via an LN-a2G bridge. Our results indicate a
cell basal lamina. Schwann cell basal lamina is com-novel role for the G domain of LN-2 in infection and
prised of laminin, type IV collagen, entactin/nidogen,reveal a model in which a host-derived bridging mole-
and heparin sulfate proteoglycans (Cornbrooks et al.,cule determines nerve tropism of a pathogen.
1983; Jaakkola et al., 1989; Sanes et al., 1990). Although
there is evidence that M. leprae binds to fibronectin
(Schorey et al., 1995), this binding may not be relevantIntroduction
for M. leprae interactions with Schwann cells in vivo,
since both fibronectin mRNA and protein are absent inMycobacterium leprae, the causitive organism for lep-
Schwann cell basal lamina in situ and in primary culturesrosy, is unique among bacterial pathogens in its ability
(Cornbrooks et al., 1983; Jaakkola et al., 1989). Con-to invade the peripheral nervous system. The neural
versely, considering the continuous presence of laminintropism of this disease has been recognized for almost
around the Schwann cell±axon unit in vivo (Cornbrooks150 years (Danielssen et al., 1848) but has remained
et al., 1983; Jaakkola et al., 1993), laminin appeared tounexplained. At present, it is estimated that 2±3 million
be a good candidate as an initial target for M. leprae.
leprosy patients in the world are physically disabled as a
Laminins (LNs) are glycoproteins comprised of three
result of damage to peripheral nerves and the attendant
polypeptide chains, a, b, and g. The a chain distin-
sensorimotor loss (Job, 1989; Noordeen et al., 1992). guishes itself by having an extra domain at the C-termi-
Clinical and histopathological evidence indicates that nus, i.e., the G domain (see Figure 5A) (Burgeson et al.,
the Schwann cell of the peripheral nerve is the principal 1994; Timpl and Brown, 1994). At least 10 genetically
target of M. leprae (reviewed in Lumsden, 1959; Muk- distinct LN chains have been identified (a1, a2, a3, a4,
herjee and Antia, 1986). Schwann cells are unable to a5, b1, b2, b3, g1, and g2), which assemble into 11
destroy the pathogens that reside intracellularly, and different LN isoforms (LN-1 to -11), each with restricted
access of therapeutic agents to this site is limited owing tissue distribution (reviewed in Timpl and Brown, 1994;
to the blood±nerve barrier. Although long-term multi- Engvall and Wewer, 1996). In the Schwann cell basal
drug treatment can achieve bacteriological cure, it does lamina, the predominant LN variant is LN-2 (merosin),
not reverse nerve-function loss in leprosy patients. which is composed of the tissue-specific a2 heavy chain
Therefore, development of therapeutic strategies that together with the b1 and g1 light chains (see Figure 5A)
interrupt the M. leprae±Schwann cell interaction will be (Leivo and Engvall, 1988; Engvall et al., 1990, 1993). LN-2
important for the prevention of nerve damage. not only forms a major basement membrane network,
The specificity of a bacterial±host cell interaction and but also enables a variety of functions of neural cells
the pattern of tissue distribution of host cell receptors (Engvall et al., 1992; Yurchenco et al., 1992; Anton et
al., 1994).determine which tissues are ultimately infected by a
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to high concentrations of LN-1 and fibronectin, satura-
tion required concentrations (1000 mg/ml) 10-fold higher
than for LN-2/4. M. leprae isolated from four different
armadillos showed similar preferential binding to LN-
2/4, as compared to other matrix proteins (data not
shown). Denaturation of LN-2/4 by heat treatment de-
creased the binding by 73% (from 1200 6 125 to 220 6
38 bacteria), suggesting that M. leprae binding to LN-
2/4 is dependent on the conformation of the laminin
molecules. Since M. leprae preferentially bind to LN-
2/4, and the difference between these isoforms is the
different assembly forms of individual LN chains, we
concluded that adherence of M. leprae may involve an
LN chain specific for LN-2/4 isoforms but not the chains
Figure 1. M. leprae Binds Preferentially to LN-2/4 shared by LN-1, -2, and -4.
Quantification of M. leprae adherence to immobilized ECM proteins.
M. leprae (5 3 108) was overlaid onto0.1 mg of ECM proteins. Number
of adherent bacteria within 0.25 mm2 grid area of each well was M. leprae Adherence to Schwann Cells
quantified after 60 min of incubation, and the data were expressed Is Mediated by LN-2
as the mean 6 SD values from 4±5 wells. Inset: binding of M. leprae
To maintain physiological functions of Schwann cells(5 3 108) to LN-2/4 with increasing concentration. Each experiment
appropriately (Bunge et al., 1990), a well-characterizedwas performed at least 3 times with similar results.
in vitro myelinating Schwann cell±neuron coculture sys-
tem was used, in which LN is expressed on the outer
surface of Schwann cell±axon units as it does in vivoThe major cell receptors for LN are the members of
(Einheber et al., 1993, 1995). Cocultures grown for 3the integrin superfamily (Hynes, 1992; Timpl and Brown,
months were inoculated with 1±5 3 108 M. leprae, and1994; Mercurio, 1995). Several integrin receptors bind
adherent bacteria were detected by acid-fast labeling.to LN (Mercurio, 1995), and a6b1 and a6b4 integrins, par-
As early as 30 min after inoculation, M. leprae was avidlyticularly the b4 subunit, appear to be involved in the
bound to and aligned along nerve fibers (Figures 2A andSchwann cell interaction with LN (Einheber et al., 1993;
2B). Adherence was dependent on bacterial dose andJaakkola et al., 1993; Feltri et al., 1994; Niessen et al.,
appeared to increase with the age of the cocultures (41994).
to 12weeks). Immunolabeling with antibodies to total LNIn this study, we provide evidence that the neural
revealed that the older cultures displayed qualitativelytropism of M. leprae involves the bacterial binding to
greater LN deposition (data not shown), suggesting thatthe G domain of the LN-a2 chain, which serves as a
increased binding of M. leprae to older cultures parallelsbridge between M. leprae and the native LN receptors
the increased expression of LN on Schwann cells. Prein-on Schwann cells. We identify the LN-a2G domain as
cubation of M. leprae with purified LN-2/4, but not type IVboth the bacterial and human cell binding site. We sug-
collagen or fibronectin, competitively inhibited M. lepraegest the b4 integrin subunit may serve as host-cell recep-
adherence to Schwann cells. Adherence in the presencetor for LN-a2G-mediated M. leprae±cell interaction. This
of BSA, LN-2/4, type IV collagen, and fibronectin wasstudy presents a remarkable example of tissue-specific
575 6 92, 98 6 26, 510 6 78, and 521 6 67 bacteriatropism of a bacterial pathogen determined by a host-
per 100 cells, respectively (p 5 0.003). Preincubation ofderived bridging molecule and a description at the mo-
cocultures with polyclonal antibodies to total placentallecular level for targeting of a bacterial pathogen to the
LN, but not type IV collagen, significantly blocked thenervous system.
binding of M. leprae (data not shown). These results
suggest that LN-2/4 plays a significant role in M. leprae
adherence to Schwann cell±neuron cultures.Results
To clarify further which LN isoform mediates the
M. leprae±Schwann cell interaction, the individual LNM. leprae Binds Preferentially to LN-2/4
To identify which extracellular matrix (ECM) protein(s) on chains expressed in Schwann cell±neuron cultures were
identified. Cocultures strongly reacted with antibodiesSchwann cell basal lamina might serve as a preferential
target of M. leprae, the adherence of M. leprae to immo- to LN-a2, -b1, and -g1 chains, but not the a1 and b2
chains (Figures 3A and 3B). The absence of the LN-a1bilized ECM proteins was quantified using a solid-phase
bacterial-adherence assay. Using 0.1 mg of immobilized chain and the expression of the b1 chain in such cultures
have been shown previously (Einheber et al., 1995).ECM proteins, it was found that M. leprae (5 3 108)
bound preferentially to merosin (LN-2 and LN-4) and Since the b2 chain is responsible for the assembly of
LN-4 (Timpl and Brown, 1994), the absence of stainingplacental LN (LN-1, -2, and -4), as compared to Engel-
breth-Holm Swarm (EHS) LN (LN-1), type IV collagen, for the b2 chain in Schwann cell±neuron cultures (Figure
3A) indicates that LN-4 is absent and that LN-2 is theheparin sulphate proteoglycan, and fibronectin (p ,
0.003) (Figure 1). Specificity and saturable binding of M. principal LN isoform in the Schwann cell basal lamina.
Therefore, the adhesion of M. leprae to the Schwannleprae to LN 2/4 was demonstrated by the concentra-
tion-, dose-, and time-dependent adhesion kinetics (Fig- cells reflects the activity of LN-2. Figure 3C demon-
strates the colocalization of M. leprae and the G domainure 1, inset; data not shown). Although M. leprae bound
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M. leprae to fresh-frozen sections of normal and homo-
zygous dy/dy sciatic nerves was compared. In control
nerve sections, M. leprae bound avidly to the endoneu-
rium, which is densely packed with Schwann cells (Fig-
ure 4A), and adhesion was inhibited by 75% in the pres-
ence of excess (200 mg/ml) LN-2/4 (reduced from 280 6
55 for control to 65 6 22 after preincubation with LN
2/4; p 5 0.005). In experiments with dy/dy mice, sections
from the distal part of the sciatic nerves were used, since
Schwann cells are frequently absent from the proximal
spinal nerves (Bradley et al., 1975). Normal presence of
Schwann cells was demonstrated by immunolabeling
using Schwann cell-specific S-100 antigen; myelination
also appeared normal (Figure 4, insets). Binding of M.
leprae to the sections of sciatic nerves from dy/dy mice
was reduced by 85% compared to controls (from 280 6
55 to 42 6 11 bacteria; p 5 0.0034) (Figure 4B). Control
FITC-labeled E. coli did not bind to the sciatic nerves
of either wild-type or dy/dy mice. The lack of adherence
of M. leprae to dy/dy nerves provides evidence for the
use of LN-a2 chain by M. leprae for the interaction with
peripheral nerves.
M. leprae Binds to the G Domain
of the LN-a2 Chain
To map the M. leprae-binding site of the LN-a2 chain,
two recombinant (r) human cDNA fragments of LN-a2
chain were expressed in a eukaryotic expression sys-
tem capable of secreting functional glycoproteins. Ex-
pressed fragments extended from the N-terminal VI, V,Figure 2. Inhibitionof M. leprae Adherence to Schwann Cell±Neuron
IVb, and the first third of domain IIIb (rLN-a2[VI±IVb]9),by LN-2
and theC-terminal G domain from G1 throughG5 subdo-Myelinating Schwann cell±neuron coculture grown for 8 weeks were
inoculated with M. leprae, and adherent bacilli were detected by mains (rLN-a2G). Both rLN-a2G and rLN-a2(VI±IVb)9
auramine-rhodamine acid-fast labeling. were secreted and could be detected in immunoblots
(A) Phase-contrast image after acid-fast staining. Inset: Nomarski with antibodies specific for LN-a2 chain.
image of intact myelinating Schwann cell culture before acid-fast
Binding of M. leprae to immobilized rLN-a2(VI±IVb)9staining.
and rLN-a2G (Figure 5A, right) was analyzed in the solid-(B) Acid-fast labeling of M. leprae corresponding to (A).
phase bacterial-adhesion assay and compared to rLN-(C) Preincubation of M. leprae with merosin±LN-2/4 (200 mg/ml).
a2G and other proteolytic fragments of LN-1 (Figure 5A,
left). M. leprae strongly bound to the C-terminal rLN-
a2G fragment, but not to the N-terminal rLN-a2(VI±IVb)9of LN-a2 chain on Schwann cell±neuron. Taken together
with the ability of M. leprae to distinguish LN-2 from fragment of the a2 chain (Figure 5B). Also, M. leprae
showed no binding to the rLN-a1G or proteolytic frag-LN-1 (Figure 1), these results suggest that bacteria spe-
cifically bind to the a2 chain of LN-2. ments of LN-1, including the E3 and E8 fragments of
native LN-a1G, even at concentrations as high as 100To determine if LN-2 could also mediate M. leprae
adherence to Schwann cells in the absence of neurons, mg/ml. Binding was dependent on the concentration of
rLN-a2G, reaching saturation at 50 mg/ml (Figure 5B,primary Schwann cells were cultured with forskolin, a
drug that elevates cAMP and mimics some of the effects inset). Preincubation of M. leprae with excess LN-2/4
(200 mg/ml) abolished the binding to rLN-a2G (10 mg/of axonal contact (Jessen and Mirsky, 1991). Binding of
M. leprae (5 3 108) increased (from 87 6 22 to 320 6 ml) by 84% (from 510 6 55 to 90 6 18 bacteria; p 5
0.0007). These results suggest that the M. leprae-bind-70 bacteria per 100 cells; p 5 0.008) when Schwann
cells were treated with forskolin. This binding correlated ing site on the laminin-a2 chain resides within the G1±G5
subdomains at the C-terminal end.with increased expression of LN-a2 chain, as compared
to untreated Schwann cells (data not shown). rLN-a2G domain binds to heparin, a property ex-
ploited in developing a purification protocol (Yurchenco
et al., 1993). To determine whether theM. leprae recogni-M. leprae Fails to Adhere to Peripheral Nerves
Deficient in LN-a2 Chain In Situ tion site was the same or different from the heparin-
binding site of the G domain, competitive inhibitionDystrophic dy/dy mice have a specific defect in the
expression of the LN-a2 chain, whereas the expression experiments were performed. Binding of M. leprae to
rLN-a2G was not affected in the presence of heparinof g1 and b1 LN chains or type IV collagen is normal
(Sunada et al., 1994; Xu et al., 1994). Using an in situ either in solid-phase or in solution, even at a concentra-
tion of 1 mg/ml (325 6 85 versus 305 6 72 bacteria).bacterial-adherence assay (Falk et al., 1993), binding of
Cell
814
Figure 3. Colocalization of M. leprae and LN-
a2G on Myelinated Nerve Fibers
(A) Immunofluorescent micrograph of 8-week-
old Schwann cell±neuron cocultures labeled
with monoclonal antibodies specific for a2,
g1, and b2 LN chains as indicated.
(B) Immunoblot analysis of LN-2 in total ly-
sates of Schwann cell±neuron cocultures.
Schwann cell±neuron extracts (lane 3) were
separated by 6% (above) and 10% (below)
SDS±PAGE, transferred to PVDF membranes,
and immunostained with PAbs to 300 kDa
fragment of LN-a2 (above) or rLN-a2G (be-
low). LN-2/4 (lane 1) and EHS LN/LN-1 (lane 2)
are shown as positive and negative controls,
respectively.
(C) Colocalization of M. leprae and the G do-
main of LN-a2 chain on myelinating Schwann
cell±neuron culture by double immunofluo-
rescence using mouse MAb to native pheno-
lic glycolipid-1 of M. leprae (in red/orange)
and PAb to rLN-a2G (in green).
This suggested that the M. leprae-binding site was inde- rLN-a2G domain directly mediates M. leprae adherence
to dy/dy nerves in situ, most probably using an existingpendent of the heparin-binding site within the a2G
domain. LN-2 receptor(s). In this context, it was found that in
situ expression of a6b4 integrin, a major LN receptor of
Schwann cells, appears to be normal in dy/dy peripheralThe G Domain of the LN-a2 Chain Mediates
M. leprae Adherence to Schwann Cells nerve (Figure 6E).
In Vitro and In Situ
To demonstrate directly that the LN-a2G domain can
mediate M. leprae adherence, rLN-a2G domain was Heterologous Model to Identify Host Cell Receptor(s)
for LN-a2G-Mediated Interaction of M. leprae:tested for the ability to enhance M. leprae adherence
to primary Schwann cells poorly expressing LN-2. Con- Role of b4 Integrin
A major LN-2 receptor on Schwann cells is the integrinfluent cultures of forskolin-treated primary Schwann
cells were inoculated with 1 3 108 M. leprae in the pres- a6b4 (Einheber et al., 1993; Jaakkola et al., 1993; Feltri
et al., 1994; Niessen et al., 1994). To test the role ofence and absence of rLN-a2G domain. M. leprae adher-
ence to Schwann cells was significantly increased in a a6b4 integrin in LN-mediated M. leprae adherence, a
heterologous model using cell lines that do not depositconcentration-dependent fashion after preincubation of
bacteria with rLN-a2G domain (Figures 6A±6D). rLN-a2G LN-a2 chain, but express a6b4 integrin, was established.
HBL-100 and Cos-7 cells strongly express a6b4 integrindid not mediate the binding of closely related Mycobac-
terium tuberculosis to Schwann cell cultures in similar and have little a6b1 (Sonnenberg et al., 1990) (Figure
7A, inset; unpublished data). Erythroleukemic K562 cellsexperimental conditions (,40 as compared to .400 M.
leprae per 100 cells). These data suggest that M. leprae± were chosen as a negative control because they only
express fibronectin receptor a5b1 integrin and lackSchwann cell interaction is specifically mediated by the
G domain of LN-a2 chain. known LN receptors, including a6b4 (Delwel et al., 1993).
None of these cell lines express detectable levels of LN-The M. leprae-binding activity of the rLN-a2G domain
was also apparent in an in situ adherence assay to sec- a2 chain, and the direct binding of M. leprae to these
cell lines was also negligible (data not shown). In thetions of sciatic nerves from dy/dy mice that lack LN-a2
chain. While M. leprae fails to adhere to dy/dy nerve in presence of LN-2/4, M. leprae adhered to HBL-100 and
Cos-7 cells, whereas only a low number of bacteria weresitu (Figure 4B), preincubation of the bacteria with rLN-
a2G domain reconstituted adherence to almost 80% of bound to K562 cells, regardless of the laminin concen-
tration (Figure 7A). Type IV collagen and fibronectin didwild-type levels (from 29 6 12 to 145 6 38 [p 5 0.009];
Figure 6F) ina concentration-dependent manner. In con- not influence the binding of M. leprae to HBL-100 and
Cos-7 cells (data not shown). rLN-a2G domain also me-trast, rLN-a2G neither increased binding tocontrol nerve
nor mediated M. tuberculosis adherence to dy/dy nerves diated M. leprae adherence to Cos-7 cells in a concen-
tration-dependent manner (Figure 7B), and this bindingin situ (data not shown). This suggests that exogeneous
Laminin-a2G Bridges M. leprae to Schwann Cells
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influenced the binding even at high concentrations (Fig-
ure 7C, inset). The inhibitory action of anti-b4 antibody
suggests that the b4 subunit of the a6b4 integrin may be
a candidate receptor mediating the M. leprae±host cell
interaction through the LN-a2G domain.
Discussion
In the present study, we provide evidence that the neural
tropism of leprosy bacilli is attributable to the specific
targeting of bacteria to the G domain of the LN-a2 chain
expressed on the Schwann cell±axon unit. The results
suggest a novel role for the G domain not only as a
bacterial binding site within the endoneurial isoform of
LN, but also as a tissue-restricted bridging molecule that
specifically mediates M. leprae attachment to Schwann
cells of the peripheral nerve. The G domain was also
identified as a cell binding site of human LN-2. We pro-
pose the LN receptor b4 integrin subunit as a candidate
receptor for the LN-a2G-mediated M. leprae±cell inter-
action.
M. leprae preferentially binds to the LN-2 isoform,
especially the a2 heavy chain. This was substantiated
by several lines of evidence. Binding to a1, b1, and
g1 LN chains was excluded by the lack of M. lepraeFigure 4. M. leprae Fails to Adhere to LN-a2 Chain-Deficient dy/dy
adherence to LN-1. The b2 LN chain was excluded byPeripheral Nerves In Situ
the binding of M. leprae to myelinating Schwann cell-In situ-adherence of M. leprae to the sciatic nerves from (A) wild-
neuron cultures expressing only a2, b1, and g1 LNtype and (B) dy/dy mice. Left insets: staining with antibody to S-100
chains. Finally, M. leprae fails to adhere to nerve sec-antigen to demonstrate the densely packed Schwann cells. Right
insets: phase-contrast image of myelinated Schwann cells in the tions of LN-a2 chain-deficient dy/dy mice in situ. Hence,
endoneurium of both wild-type and dy/dy nerves. Experiment was LN-a2 chain was found to be necessary and sufficient
repeated three times from two dy/dy and two control mice with for adherence to Schwann cells. Our data also suggest
similar results.
that M. leprae binds to LN-a2 chain regardless of its
origin, since this bacteria avidly binds to rat and murine
LN-a2 in vitro and in situ, and this binding can be com-was more effective as compared to total LN-2/4 (Figures
petitively inhibited by human LN-2/4.
7A and 7B). In contrast, rLN-a2(VI±IVb)9 or rLN-a1G did
The preferential binding of M. leprae to the surface
not mediate bacterial adherence to Cos-7 cells even at
of cultured Schwann cells (reviewed in Lumsden, 1959;
high concentration (100 mg/ml). Binding of 1 3 108 M.
Mukherjee and Antia, 1986) may be explained by the
leprae in the presence of 25 mg/ml of rLN-a2G, rLN- affinity of M. leprae for LN-a2 chain, since the binding
a2(VI±IVb)9, and rLN-a1G was 369 6 19, 19 6 8, and varies in proportion to the amount of LN-a2 chain. Previ-
10 6 3 bacteria per 100 cells, respectively (p 5 0.001). ous studies have also shown that M. leprae readily ad-
Furthermore, rLN-a2G failed to mediate binding of heres to Schwannoma cell lines (Maeda and Narita,
closely related M. tuberculosis and nonrelated B. subtilis 1987). This can be attributed to the large amount of LN-
(gram positive) and E. coli (gram negative) to Cos-7 a2 polypeptide expressed by these cells (Engvall, 1993).
cells (Figure 7B, inset). These data suggest that specific Conversely, although fibronectin can mediate attach-
binding of M. leprae to rLN-a2G mediates the bacterial ment of M. leprae to epithelial and Schwannoma cell
adherence to a6b4-bearing host cells. lines (Schorey et al., 1995), this mechanism is unlikely
To determine whether LN-a2G-mediated M. leprae± to be operative in vivo, as Schwann cells fail to express
Cos-7 cell interaction can be blocked by antibodies to fibronectin in primary culture or in situ (Cornbrooks et
known LN-receptor integrins, confluent cultures of al., 1983; Jaakkola et al., 1989).
Cos-7 cells were preincubated with previously charac- Various LN isoforms differ extensively with respect to
terized blocking MAbs against b1, b4, a2, a3, a4, and a6 their tissue distribution in vivo (Engvall et al., 1990; Timpl
integrin subunits, prior to the addition of M. leprae (1 3 and Brown, 1994). LN-2 is restricted to the basal lamina
108) treated with 25 mg/ml rLN-a2G. Among the anti- of Schwann cells, striated muscles, and trophoblast of
integrin MAbs tested, MAb 3E1, which is directed to the the placenta (Leivo and Engvall, 1988; Engvall et al.,
extracellular domain of the b4 integrin subunit, signifi- 1990, Engvall, 1993). Interestingly, the presence of M.
cantly inhibited laminin-a2G-mediated M. leprae adher- leprae in striated muscles of leprosy patients is a com-
ence to Cos-7 cells (from 330 6 55 to 85 6 32 bacteria mon phenomenon and has also been demonstrated in
per 100 cells; p 5 0.007) (Figure 7C). Despite the expres- murine models of leprosy (Pearson et al., 1970; Esiri et
sion of a6 integrin on Cos-7 cells, GOH3 MAb, which al., 1972). Moreover, M. leprae invasion of the placenta
is known to block a6 integrin-mediated cell adhesion in murine models of leprosy has been documented (Dun-
(Sonnenberg et al., 1990), had almost no effect. None can et al., 1984) and may be responsible for the intrauter-
ine dissemination of M. leprae (Duncan et al., 1983). Itof the otheranti-integrin MAbs, including anti-b1 subunit,
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Figure 5. M. leprae Binds to the G Domain of
the LN-a2 Chain
(A) Diagram of LN-1 (left) and LN-2 (right) mol-
ecules and their recombinant proteins (dotted
lines) and proteolytic fragments (solid lines).
Numbering and cleavage site (shown by the
arrow) of the G subdomains are indicated.
(B) M. leprae binding to immobilized protein
fragments of LN-1 and LN-a2, and total LN-
2/4 (merosin). Left inset: Coomassie blue-
stained SDS±PAGE gel showing the purity of
rLN-a2G (120 kDa, right lane) and the molecu-
lar mass standard (shown in kilodaltons by
the arrowheads, left lane). Right inset: the
binding of M. leprae to increasing concentra-
tions of rLN-a2G domain (mean 6 SD from 3
determinations).
appears, therefore, that the tissue distribution of LN-2 discontinous presence of surface LN. Exogenous LN
can bind these exposed receptors and thereby enhancecorrelates with sites of natural M. leprae infection. The
present study provides a demonstration that a host- M. leprae interactions. Similarly, rLN-a2G domain signif-
icantly increased the binding of M. leprae to forskolin-derived bridging molecule determines tissue-specific
tropism of a bacterial pathogen. treated Schwann cells. Furthermore, although M. leprae
failed to bind to dy/dy nerves, rLN-a2G reconstitutedLN-a2 chain is processed in tissues into a 300 kDa
N-terminal segment and an 80 kDa C-terminal segment the binding to almost 80% of wild-type levels, sug-
gesting that rLN-a2G directly mediates M. leprae inter-that includes the G domain (G2 through G5 subdomains;
Figure 5A) (Leivo and Engvall, 1988). Mapping of the M. action with LN receptor in dy/dy nerve lacking LN-a2
chain.leprae-binding site using recombinant LN-a2 fragments
revealed that M. leprae specifically binds to the C-termi- Study of the cell-binding activity of the G domain has
been extremely difficult, since the isolated G domainnal G domain. Lack of M. leprae binding to the analogous
rLN-a1G is consistent with the particularly high se- does not retain activity or native conformation (Deutz-
mann et al., 1990; Sung et al., 1993). Consistent withquence divergence of a1 and a2G domains (Sasaki et
al., 1988; Vuolteenaho et al., 1994). The M. leprae-bind- this experience, rLN-a2G alone had a weak cell-binding
activity (data not shown). Interestingly, in the presenceing site of the a2G domain is also apparently indepen-
dent of the heparin-binding subdomain (Yurchenco et of M. leprae, rLN-a2G strongly bound to primary
Schwann cells and Cos-7 cells, suggesting that specifical., 1993). It remains to be demonstrated directly that
M. leprae binds to the proximal G1±G3 subdomains. association of M. leprae and rLN-a2G alters the G do-
main such that it becomes competent for cell binding.Exogeneous LN-2/4 competitively inhibited M. leprae
binding to Schwann cell±neuron cultures characterized These data demonstrate that the G domain, in addition
to being the site for M. leprae binding, also serves as aby the continuous presence of LN-2 on the cell surface.
In forskolin-treated Schwann cells, a significant portion cell-binding site of human LN-2. This system could be
a useful model for the identification of cell-surface LNof LN receptors may be unoccupied, resulting in the
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Figure 6. Role of rLN-a2G Domain in M. leprae Adherence to Schwann Cells In Vitro and In Situ
(A) M. leprae (1 3 108) were preincubated with increasing concentrations of rLN-a2G, rLN-a2(VI±IVb)9, rLN-a1G, and E3 1 E8 proteolytic
fragments of LN-1 before addition to confluent cultures of forskolin-treated primary Schwann cells. Numbers of Schwann cell-bound M. leprae
were counted and data were expressed as mean 6 SD from 3 determinations. The experiment was repeated twice with similar results.
(B±D) M. leprae adherence to 10-day-old forskolin-treated primary Schwann cells in the presence of N-terminal r(VI±IVb)9 (C) and C-terminal
rG (D) fragments (25 mg/ml) of the LN-a2 chain. Inset (D) shows higher magnification of Schwann cell-bound M. leprae. Phase-contrast image
of (C) is shown in (B).
(E) In situ expression of LN receptor b4 integrin in dy/dy sciatic nerve. Sections of dy/dy nerves were incubated with PAb to b4 cytoplasmic
domain (1:50), and bound antibody was visualized by rhodamine-labeled secondary antibody.
(F) In situ adherence to fresh-frozen sections of dy/dy sciatic nerve of M. leprae preincubated with excess (100 mg/ml) rLN-a2G.
receptors and for delineation of the role of LN-a2G in adherence in situ. However, we were unable to confirm
this, as no blocking antibodies are available to murinecell±matrix interaction in peripheral nerves and muscles.
In particular, this may be of relevance to congenital b4. Conversely, although Cos-7 cells strongly express
a6 integrin, the only known partner for b4, i.e., blockingmuscular dystrophy and the murine dy/dy model, where
LN-a2 plays an important role in the pathogenesis of antibody GOH3 against the a6 subunit, showed no signif-
icant inhibitory effect on a2G-mediated M. leprae bind-muscle degeneration and peripheral neuropathy (Camp-
bell, 1995). ing to Cos-7 cells. This may be due to the involvement
of the nonactive site of a6 integrin for LN-a2G binding.The ability of rLN-a2G to bind efficiently to Cos-7 cells
in the presence of M. leprae enabled the identification of It is also possible that a new integrin subunit, as yet
unidentified, associated with b4 might be involved inthe cell-surface integrins involved in rLN-a2G-mediated
cell binding independent of the influence of other re- this interaction. Of interest, recent data suggest that
a-dystroglycan may also serve as a Schwann cell recep-gions of the laminin molecule. Our results show that
rLN-a2G-mediated M. leprae binding is partially blocked tor for LN-2 (Yamada et al., 1996). Therefore, we cannot
exclude the possibility of the involvement of a-dystro-by MAb 3E1 against the b4 integrin subunit, suggesting
that cell-surface b4 integrin may be a candidate receptor glycan in M. leprae±Schwann cell interaction.
In conclusion, LN-a2G on Schwann cell basal laminainvolved in the rLN-a2G-mediated attachment. Further-
more, since b4 integrin is normally expressed in dy/dy serves as a neural target of M. leprae, and the LN-a2
chain is necessary and sufficient for adherence tonerve (Figure 6E) and M. leprae adhered to dy/dy nerve
only in the presence of rLN-a2G, b4 integrin may mediate Schwann cells. Details of this interaction will clarify
Cell
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questions in LN matrix biology, especially those related
to the G domain, using novel assays described herein.
We also provide evidence that the LN receptor b4 integrin
may be involved in LN-a2G-mediated M. leprae±cell in-
teraction. We propose that specific interaction of M.
leprae with neural- and muscle-restricted LN-a2 is the
basis for the neural tropism of M. leprae.
Experimental Procedures
Bacteria
M. leprae, isolated from four armadillos, was provided by Dr. P. J.
Brennan (Colorado State University, Fort Collins, CO). M. leprae was
detected either by using auramine-rhodamine Bacto TB Fluorescent
Stain Kit (Difco, Detroit, MI) (Schlesinger and Horwitz, 1991), or
by antibody to M. leprae-specific phenolic glycolipid (PGL-1). M.
tuberculosis gamma-irradiated strains H37Rv and live avirulent
H37Rawere provided by Drs. P.J. Brennan and G. Kaplan (Rockefel-
ler University, NY), respectively. B. subtilis and E. coli strain DH5a
were provided by Dr. H. R. Masure (Rockefeller University, NY).
Antibodies
The following polyclonal (PAb) and monoclonal (MAb) antibodies to
LN and LN chains were used: affinity-purified rabbit PAb to human
placental LN (LN-2/4) (GIBCO±BRL, Gaithersberg, MD) and EHS LN
(LN-1) (Sigma, St. Louis, MO); MAbs 2E8 and D18 to g1/B1 LN chain;
MAbs D5 and D7 to b2/S LN chain; MAb M3F7 to type IV collagen
(Developmental Studies Hybridoma Bank, University of Iowa, IA,
and Johns Hopkins University School of Medicine, Baltimore, MD);
MAb 5H2/H6 to a2/M LN chain (Dr. E. Ingvall, La Jolla Cancer Re-
search Foundation, La Jolla,CA); PAb 321 against 300 kDa fragment
of a2 LN chain (Dr. M. Paulsson, University of Cologne, Cologne,
Germany); and rabbit PAb against E3 fragment (LN-a1G4/5) (Yur-
chenco et al., 1993).
The following antibodies to integrin subunits were used: MAb
P4C10 to b1; MAb 3E1 to b4 (GIBO±BRL); mouse MAbs 450±9D,
450±10D, and 450±11A, and rat MAb 439±9B to b4 (Dr. S. J. Kennel,
Oak Ridge National Laboratories, Oak Ridge, TN); rabbit PAb against
synthetic peptides of carboxy-terminal sequences of b4 (Dr. F. Gian-
cotti, Memorial Sloan-Kettering Cancer Center, New York, NY); rat
blocking MAb GOH3 to a6 (Dr. A. Sonnenberg, Amsterdam, The
Netherlands); and blocking MAbs P1E6 to a2, P1B5 to a3, and P4G9
to a4 (Dako, Santa Barbara, CA).
MAb F47±21 (IgG1) to M. leprae-specific native PGL-1 was a gift
from Dr. A. H. J. Kolk (Royal Tropical Institute, Amsterdam). IgG
fraction of rabbit PAb to S-100 antigen and mouse IgG isotype
control antibodies were from Sigma and Dako, respectively.
Figure 7. Involvement of LN Receptor in LN-a2G-Mediated M. le-
prae Adherence LN and Other Matrix Proteins
Human placental LN, murine EHS tumor LN (LN-1), human fibro-(A) LN-2/4-mediated M. leprae adherence to cell lines with and with-
nectin, heparin sulfate proteoglycan, and heparin were obtainedout LN receptor. HBL-100, Cos-7, and K562 cell lines were inocu-
from Sigma (St. Louis, MO). Human merosin (LN-2/4) used in thislated with M. leprae pretreated with excess LN-2/4. Numbers of
study was from GIBCO±BRL and Dr. M. Paulsson. Human type IVadherent M. leprae were quantified and expressed as mean 6 SD
collagen was purchased from Collaborative Biomedical Productsper 100 cells. Insets display expression of b4 on Cos-7 cells: above,
(Bedford, MA).immunoblotting of the lysates of Cos-7 (lane 1) and K562 (lane 2)
using anti-b4 MAb 3E1; below, immunofluorescence labeling of b4
expression on Cos-7 cells as detected by MAb 3E1 (1:50) (anti-a6 Preparation of Recombinant Human LN-a2G Domain
integrin MAb also showed similar activity). and Antibody
(B) M. leprae was preincubated with increasing concentrations of A l-clone encoding the distal portion of the human LN-a2 chain
rLN-a2G before addition to confluent cultures of Cos-7 cells. Inset: (clone 271 kindly provided by Dr. E. Engvall) was restricted between
comparison of the effect of rLN-a2G on adherence of M. leprae, M. TthIIII and EcoR1 and subcloned into Blue Script KS. An AsnII±
tuberculosis, B. subtilis, and E. coli to Cos-7 cells. BamH1 fragment was ligated into the modified baculovirus expres-
(C) Effects of anti-integrin MAbs on rLN-a2G-mediated M. leprae sion vector pVL1392ss (Yurchenco et al., 1993) previously restricted
binding to Cos-7 cells. Confluent cultures of Cos-7 cells were prein- with PstI and BamH1, using the complementing synthetic oligonu-
cubated with indicated MAbs prior to the addition of rLN-a2G- cleotides 59-GGTGACTGCATT-39 and 39-ACGTCCACTGACGTA
treated M. leprae. Number of cell-bound bacteria were counted and AGC-59 as a linker. Insect Sf9 cells were transfected and recombi-
data expressed as inhibition of adherence (percentage of control) nant baculovirus was selected as previously described (Yurchenco
or adherence per 100 cells (inset) from 3 determinations. The experi- et al., 1993). Recombinant glycoprotein, which was secreted, was
ment was repeated twice with similar results. Inset: dilution effect purified from conditioned medium by heparin affinity chromatogra-
of anti-b1 and anti-b4 MAbs on rLN-a2G-mediated M. leprae adher- phy, also as described.
ence to Cos-7 cells. A New Zealand white rabbit was immunized with purified protein
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in complete Freund's adjuvant and boosted two weeks later in in- 378C before adding to the cultures. For antibody-inhibiting studies,
Schwann cell±neuron cultures were incubated for 1 hr at 378C withcomplete Freund's adjuvant. The pooled sera were purified by pro-
tein A affinity chromatography. The antibody reacted in ELISA z100 mg of affinity-purified antibodies to total placental LN (LN-2/4)
and type IV collagen, and cultures were washed before inoculationassays and in Western blots, with the G domain of LN containing
the a2 chain, but not the a1 chain. The antibody was also evaluated with M. leprae. To determine M. leprae binding to primary Schwann
cells, confluent cultures of forskolin-treated Schwann cells grownby immunofluorescence with frozen sections of human skeletal mus-
cle and peripheral nerves. The antibody reacted in a restricted fash- (10±14 days) in 8-well Lab-Tek chamber slides (Nunc) were used.
To evaluate the effects of LNs and their fragments on M. lepraeion with the perimyotubular basement membranes and Schwann
cell basal lamina. binding to primary Schwann cells, bacteria were preincubated with
either 100 mg/ml total LN or 25 mg/ml of LN fragments for 1 hr atRecombinant a2(VI±IVb)9 was prepared from 293 mammalian cells
transfected with pCIS-human LN a2(VI±IVb)9 cDNA (H. Colognato- 378C before inoculation.
Assay of M. leprae Adherence to HeterologousPyke and P. D. Y., unpublished data). The protein was purified from
conditioned medium as described (Colognato-Pyke et al., 1995). Model Cell Lines
M. leprae adherence to HBL-100, COS-7, and K562 cell lines wasPreparation, purification, and characterization of recombinant LN-
a1G domain have been previously described (Yurchenco et al., assayed in 8-well Lab-Tek chamber slides. M. leprae was preincu-
bated with LN-2/4 or rLN-a2G for 1 hr at 378C, then added to the1993). Proteolytic fragments of LN-1 were prepared as previously
described (Yurchenco et al., 1993). cells for 30 min at 378C, followed by washing. For inhibition studies,
confluent cultures were incubated with antibodies against LN-
receptor integrin subunits for 1 hr at 378C before inoculation withPrimary Schwann Cells and Schwann
M. leprae pretreated with LN-2/4 or rLN-a2G.Cell±Neuron Cocultures
In Situ Adherence Assay for M. lepraeCultures of primary rat Schwann cells, dorsal root ganglion (DRG)
M. leprae adherence to peripheral nerve sections in situ was deter-neurons, and myelinating Schwann cells±DRG neurons were estab-
mined by adapting the protocol of Falk et al. (1993). In brief, 7±8lished as described previously (Einheber et al., 1993). In some exper-
mm thick fresh-frozen sections of sciatic nerves from control andiments, Schwann cells were grown on poly-L-lysine-coated Lab-tek
dy/dy mice were rinsed inPBS and then incubatedfor 1 hr inblocking8-well chamber slides (Nunc Inc., Naperville, IL) in standard media
buffer (0.2% BSA, 0.01% Tween-20 prepared in PBS). M. lepraeand were continuously treated with a crude preparation of GGF and
suspension was diluted to 1 3 106 to 1 3 108 bacteria/ml in blocking2 mM forskolin.
buffer, and 100 ml was applied to the sections, which were thenTo establish myelinating Schwann cell±neuron cocultures, DRGs
incubated for 30 min at 378C. Slides were washed at least 6 timeswere removed from E15 or E16 rats, dissociated with trypsin, and
with PBS, fixed with 2.5% glutaraldehyde, and numbers of tissue-grown on collagen-coated glass coverslips in a 4-well dish (Nunc).
adherent bacteria per 5 randomly selected high power fields wereCultures were cycled with antimitotic agents in standard serum-
counted. For inhibition studies, the bacterial suspension was prein-containing media to remove nonneuronal cells. DRG neuron cultures
cubated with excess LN proteins (200 mg/ml) for 1 hr at 378C priorwere seeded with 2 3 105 Schwann cells in standard media. After
to incubation with sections.24 hr, the standard media were replaced with N2-defined media in
which Schwann cells proliferate but do not assemble basal lamina
or myelinate (Moya et al., 1980). After several days, media were Immunofluorescence Microscopy
supplemented with 50 mg/ml ascorbic acid to promote basal lamina Immunolabeling was performed as previously described (Rambuk-
formation and initiate myelination. kana et al., 1993). In brief, slides were incubated with 2% BSA
in DPBS and then incubated with primary antibodies. Slides were
Cell Lines washed and treated with species-specific affinity-purified rhoda-
The following cell lines were used: human mammary cell line HBL- mine- or FITC-conjugated swine anti-rabbit IgG or rhodamine- or
100; human erythroleukemic cell line K562 (Dr. A. Sonnenberg, The fluorescein-conjugated rabbit anti-mouse IgG (Chemicon Interna-
Netherlands Cancer Institute, Amsterdam); and COS-7 (ATCC tional, Inc., Temecula, CA). For double-labeling, cultures were incu-
CRL1651). The cells were grown in DMEM supplemented with 10% bated with the mixure of mouse MAb (IgG1) to M. leprae phenolic
fetal bovine serum, penicillin, and streptomycin. glycolipid-1 and rabbit antibody to LN-a2G, followed by a mixture
of rhodamine-conjugated goat anti-mouse IgG and fluorescein-con-
Bacterial Adherence Assays jugated swine anti-rabbit IgG. All incubations were carried out at
LN Binding Assay room temperature for 1 hr. Slides were washed in DPBS, mounted,
Terasaki plates (Robbins Scientific, Sunnyvale, CA) were coated and examined by epifluorescence with a Nikon microscope.
overnight at room temperature (Van der Flier et al., 1995) with 0.1
mg of LNs, type IV collagen, heparin sulfate proteoglycan, heparin,
Immunoblottingfibronectin, or recombinant and proteolytic fragments of LNs (0.25
Cell lysates of confluentcultures of primary Schwann cells, epithelial
mg). Saline or bovine serum albumin (BSA) served as negative con-
cell lines, and myelinating Schwann cell±neuron cocultures weretrols. Nonspecific binding was blocked with 5% BSA for 3 hr at 378C
prepared as described previously (Einheber et al., 1993). Twenty-and then washed 5 times with DPBS. Ten microliters of bacterial
five micrograms of protein from each lysate was fractionated on 6%suspension (5 3 108 bacteria/ml) was added to each well and incu-
and 10% SDS-polyacrylamide gels and blotted onto polyvinylidenebated for 1 hr at 378C. Unbound bacteria were removed by washing
difluoride membrane (BIO-RAD, Richmond, CA). Blots were incu-5 times with DPBS. After fixation with 2.5% glutaraldehyde (Sigma)
bated with primary antibodies followed by species-specific horse-for 10 min, bacteria were stainedwith acid-fast staining and counted
radish peroxidase-labeled affinity-purified goat anti-rabbit or goatvisually under a fluorescence microscope. M. leprae adherence was
anti-mouse antibodies (BioRad), and the reaction was developed byexpressed as the number of attached bacteria per 0.25 mm2-cali-
enhanced chemiluminescence-detection method (Amersham Intl.).brated grid area using 203 magnification, and net binding was cal-
culated by subtracting theadherence to saline- or BSA-coatedwells.
Each experiment was repeated 3±4 times. Animals and Histological Examination of Tissues
C57BL/6 strain dystrophic homozygous dy/dy mice (7±8 weeks) andAssay for M. leprae Adherence to Schwann Cells±Neurons
Schwann cell±neuron cocultures grown for 8±10 weeks were inocu- age-matched normal control 1/1 mice were obtained from Jackson
Laboratory (Bar Harbor, ME). Sciatic nerves from both control andlated with 1±5 3 108 M. leprae. After 30 min at 378C in 5% CO2,
cultures were washed 5±6 times with DMEM without serum and dy/dy mice were removed; a portion of each was snap frozen, and
the other was embedded in paraffin using routine techniques. Sec-fixed in 2.5% glutaraldehyde. M. leprae bound to Schwann cell±
neuron was detected, and the number of M. leprae adherent to 100 tions were cut and immunofluorescence with antibodies to LN-a2
chain detected essentially normal expression of LN-a2 in the nervecells (counted on the basis of nuclei) was determined visually. For
competitive inhibition studies, M. leprae was preincubated with 200 sections of control mice, whereas no LN-a2 was detected in dy/dy
mice.mg/ml merosin (LN-2/4), type IV collagen, or fibronectin for 1 hr at
Cell
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Statistical Analysis Einheber, S., Milner, T.A., Giancotti, F., and Salzer, J.L. (1993). Axo-
nal regulation of Schwann cell integrin expression suggests a roleAll results were expressed as mean 6 SD. Statistical analysis of the
data were performed using Welch's t test for unpaired data with for alpha 6 beta 4 in myelination. J. Cell Biol. 123, 1223±1236.
Instat software (Graphpad). Statistical significance was accepted Einheber, S., Hannocks, M.J., Metz, C.N., Rifkin, D.B., and Salzer,
for p , 0.05. J.L. (1995). Transforming growth factor-beta 1 regulates axon/
Schwann cell interactions. J. Cell Biol. 129, 443±458.
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